Oncotarget

Research Papers:

Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXRα by K48/K63-linked polyubiquitination

Wen-Na Shi, Shu-Xiang Cui, Zhi-Yu Song, Shu-Qing Wang, Shi-Yue Sun, Xin-Feng Yu, Ye Li, Yu-Hang Zhang, Zu-Hua Gao and Xian-Jun Qu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:39605-39617. https://doi.org/10.18632/oncotarget.17174

Metrics: PDF 1211 views  |   HTML 1290 views  |   ?  


Abstract

Wen-Na Shi1, Shu-Xiang Cui2, Zhi-Yu Song1, Shu-Qing Wang1, Shi-Yue Sun1, Xin-Feng Yu1, Ye Li1, Yu-Hang Zhang1, Zu-Hua Gao3 and Xian-Jun Qu1

1Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China

2Beijing Key Laboratory of Environmental Toxicology, Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, China

3Department of Pathology, McGill University, Montreal, Quebec, Canada

Correspondence to:

Xian-Jun Qu, email: quxj@ccmu.edu.cn

Zu-Hua Gao, email: zu-hua.gao@mcgill.ca

Keywords: sphingosine kinase 2 (SphK2), retinoid therapy resistance, cytoplasmic RXRα, polyubiquitination

Received: December 06, 2016     Accepted: March 26, 2017     Published: April 18, 2017

ABSTRACT

The resistance mechanisms that limit the efficacy of retinoid therapy in cancer are poorly understood. Sphingosine kinase 2 (SphK2) is a highly conserved enzyme that is mainly located in the nucleus and endoplasmic reticulum. Unlike well-studied sphingosine kinase 1 (SphK1) located in the cytosol, little has yet understood the functions of SphK2. Here we show that SphK2 overexpression contributes to the resistance of all-trans retinoic acid (ATRA) therapy in colon cancer through rapid degradation of cytoplasmic retinoid X receptor α (RXRα) by lysine 48 (K48)- and lysine 63 (K63)-based polyubiquitination. Human colonic adenocarcinoma HCT-116 cells transfected with SphK2 (HCT-116Sphk2 cells) demonstrate resistance to ATRA therapy as determined by in vitro and in vivo assays. Sphk2 overexpression increases the ATRA-induced nuclear RXRα export to cytoplasm and then rapidly degrades RXRα through the polyubiquitination pathway. We further show that Sphk2 activates the ubiquitin-proteasome system through the signal mechanisms of (1) K48-linked proteosomal degradation and (2) K63-linked ubiquitin-dependent autophagic degradation. These results provide new insights into the biological functions of Sphk2 and the molecular mechanisms that underlie the Sphk2-mediated resistance to retinoid therapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 17174